Workflow
Ligand(LGND) - 2024 Q2 - Earnings Call Transcript
LGNDLigand(LGND)2024-08-07 02:58

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Todd Davis - CEO Tavo Espinoza - CFO Paul Hadden - Senior Vice President of Investments and Business Development Karen Reeves - Senior Vice President of Investments and Head of Clinical Strategy Conference Call Participants Matt Hewitt - Craig-Hallum Douglas Miehm - RBC Capital Markets Lawrence Solow - CJS Operator Thank you for standing by. My name is Pam and I will be your conf ...